ETHINYL ESTRADIOL 0.03 MG LEVONORGESTREL 0.15 MG
About This Opportunity
TranslatedThis tender concerns the procurement of Ethinyl Estradiol 0.03 mg and Levonorgestrel 0.15 mg. These are active pharmaceutical ingredients commonly used in combined oral contraceptive pills. The specific formulation and dosage indicate a requirement for a medication designed for hormonal contraception. The tender likely seeks to secure a supply of this pharmaceutical product for public health programs, distribution through healthcare facilities, or for inclusion in national formularies. Potential bidders are expected to be manufacturers or authorized distributors of pharmaceutical products, capable of meeting stringent quality standards and regulatory requirements for medicinal substances. Key aspects of the tender will likely include specifications for the active pharmaceutical ingredients, packaging requirements, shelf-life, and delivery timelines. Compliance with Good Manufacturing Practices (GMP) and relevant pharmacopoeial standards will be essential. The procurement aims to ensure the availability of essential reproductive health medicines, contributing to public health outcomes and family planning initiatives. Further details regarding the quantity required, the duration of the supply contract, and specific technical evaluation criteria will be provided in the full tender documentation. Interested parties should review the complete tender package to understand all obligations and submission procedures.
This is a supplies contract in the health and medical services, trade and industry and information and communication technology sectors, with a focus on Pharmaceuticals, Software and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishThis tender, issued by a contracting authority in Chile through the mercadopublico platform, seeks the supply of a pharmaceutical product: Ethinyl Estradiol 0.03 mg and Levonorgestrel 0.15 mg. This combination medication is commonly used as an oral contraceptive. The procurement is for a critical supply of this pharmaceutical, likely to meet public health needs or to replenish existing stocks within a healthcare system.
Suppliers are invited to submit proposals for the provision of this specific drug formulation. Typical requirements for such pharmaceutical tenders include adherence to stringent quality control standards, compliance with national and international pharmaceutical regulations (such as Good Manufacturing Practices - GMP), and the ability to provide detailed product specifications, including batch numbers, expiry dates, and certificates of analysis. Bidders will likely need to demonstrate their capacity for reliable and timely delivery within Chile. Furthermore, proposals may be evaluated based on competitive pricing, the supplier's track record in supplying similar pharmaceutical products, and their understanding of the Chilean regulatory environment for medicines. The contracting authority will be seeking a reputable and qualified supplier capable of ensuring a consistent and high-quality supply of this essential medication. Further details regarding specific quantities, delivery schedules, and evaluation criteria will be provided in the full tender documents.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 1 day ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
EXELTIS CHILE SPA was awarded the contract for CLP 137,999,070. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to EXELTIS CHILE SPA. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.